Search research articles
Contact Us
Filters
Showing results (121-130 of 173) with videos related to
Page
of 18
Sort By:
The Lancet. Oncology
|
February 10, 2016
Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study
Scott Antonia, Sarah B Goldberg, Ani Balmanoukian, et al.
Analytical Chemistry
|
June 1, 2023
Trace Actinide Signatures of a Bulk Neptunium Sample
Sean D Reilly, Genna M Patton, Jesse Murillo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 20, 2012
A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancer
Christelle Clément-Duchêne, Ronald B Natale, Thierry Jahan, et al.
Geochimica Et Cosmochimica Acta
|
April 16, 2019
The origin of the unique achondrite Northwest Africa 6704: Constraints from petrology, chemistry and Re-Os, O and Ti isotope systematics
Yuki Hibiya, Gregory J Archer, Ryoji Tanaka, et al.
Clinical Lung Cancer
|
March 17, 2020
Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based Chemotherapy
Susanne M Arnold, Kari Chansky, Maria Q Baggstrom, et al.
The Planetary Science Journal
|
March 8, 2021
Chromium Isotopic Evidence for Mixing of NC and CC Reservoirs in Polymict Ureilites: Implications for Dynamical Models of the Early Solar System
Cyrena A Goodrich, Matthew E Sanborn, Qing-Zhu Yin, et al.
American Journal of Clinical Oncology
|
May 22, 2018
A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer
Emerson Y Chen, Charles D Blanke, Daniel G Haller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2021
Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies
Melissa Johnson, Anthony El-Khoueiry, Navid Hafez, et al.
Journal for Immunotherapy of Cancer
|
July 24, 2021
CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study
Rachel E Sanborn, Omid Hamid, Elisabeth Ge de Vries, et al.
Ophthalmology. Retina
|
October 24, 2022
The Predictive Value of False-Positive ForeseeHome Alerts in the ALOFT Study
Allen C Ho, Sidney A Schechet, Mariam Mathai, et al.
Page
of 18
Search research articles
Search
Showing results (121-130 of 173) with videos related to
Sort By:
Page
of 18
The Lancet. Oncology
|
February 10, 2016
Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study
Scott Antonia, Sarah B Goldberg, Ani Balmanoukian, et al.
Analytical Chemistry
|
June 1, 2023
Trace Actinide Signatures of a Bulk Neptunium Sample
Sean D Reilly, Genna M Patton, Jesse Murillo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 20, 2012
A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancer
Christelle Clément-Duchêne, Ronald B Natale, Thierry Jahan, et al.
Geochimica Et Cosmochimica Acta
|
April 16, 2019
The origin of the unique achondrite Northwest Africa 6704: Constraints from petrology, chemistry and Re-Os, O and Ti isotope systematics
Yuki Hibiya, Gregory J Archer, Ryoji Tanaka, et al.
Clinical Lung Cancer
|
March 17, 2020
Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based Chemotherapy
Susanne M Arnold, Kari Chansky, Maria Q Baggstrom, et al.
The Planetary Science Journal
|
March 8, 2021
Chromium Isotopic Evidence for Mixing of NC and CC Reservoirs in Polymict Ureilites: Implications for Dynamical Models of the Early Solar System
Cyrena A Goodrich, Matthew E Sanborn, Qing-Zhu Yin, et al.
American Journal of Clinical Oncology
|
May 22, 2018
A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer
Emerson Y Chen, Charles D Blanke, Daniel G Haller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2021
Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies
Melissa Johnson, Anthony El-Khoueiry, Navid Hafez, et al.
Journal for Immunotherapy of Cancer
|
July 24, 2021
CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study
Rachel E Sanborn, Omid Hamid, Elisabeth Ge de Vries, et al.
Ophthalmology. Retina
|
October 24, 2022
The Predictive Value of False-Positive ForeseeHome Alerts in the ALOFT Study
Allen C Ho, Sidney A Schechet, Mariam Mathai, et al.
Page
of 18